{[9-(Ethyl-methyl-amino)-5,9a-dihydroxy-9b-methyl-1,2,3,3a,8,9,9a,9b-octahydro-phenanthro[4,5-bcd]furan-3-ylcarbamoyl]-methoxy}-acetic acid

ID: ALA2112085

PubChem CID: 13894004

Max Phase: Preclinical

Molecular Formula: C21H26N2O7

Molecular Weight: 418.45

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(NC(=O)COCC(=O)O)CC[C@@]3(O)[C@H]1C5

Standard InChI:  InChI=1S/C21H26N2O7/c1-23-7-6-20-17-11-2-3-13(24)18(17)30-19(20)12(4-5-21(20,28)14(23)8-11)22-15(25)9-29-10-16(26)27/h2-3,12,14,19,24,28H,4-10H2,1H3,(H,22,25)(H,26,27)/t12?,14-,19+,20+,21-/m1/s1

Standard InChI Key:  MLDIPUCZHTVXQG-NJOVEUHHSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  1  0  0  0  0  0999 V2000
    8.6849   -3.1131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6561   -2.2736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9698   -3.5596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4102   -3.5054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9953   -4.3879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0059   -4.2527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9235   -1.8772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2339   -3.1519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2067   -2.3181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1320   -3.0815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3745   -1.8383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8810   -3.4914    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2768   -4.8231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5944   -3.0393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2366   -1.0096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1178   -5.5539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5227   -3.5911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1161   -2.2443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0237   -1.2791    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5825   -2.1947    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8763   -5.9548    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5329   -4.4300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3586   -4.3050    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3993   -5.9891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3107   -5.6795    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3451   -3.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1042   -4.7037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5086   -1.4538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8122   -0.3834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8526   -2.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1296   -4.2000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.1477   -1.2462    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  1  1  0
  5  3  2  0
  4  6  1  0
  7  2  1  0
  8  3  1  0
  9  8  1  0
 10  4  1  0
 11  2  1  0
 12 10  1  0
 13  5  1  0
 14 12  1  0
 15  7  1  0
 16 27  1  0
 17  8  2  0
 18 10  1  0
  2 19  1  1
 20 14  2  0
 21 16  2  0
 22 17  1  0
  1 30  1  1
 23 26  1  0
 24 16  1  0
 25 13  1  0
 26 14  1  0
 27 23  1  0
 28 15  1  0
 29 15  1  0
 30 28  1  0
  6  5  1  0
 11 18  1  0
  7  9  1  0
 13 22  2  0
  4 31  1  1
  7 32  1  6
M  END

Associated Targets(Human)

OPRK1 Tclin Opioid receptors; mu/kappa/delta (568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 418.45Molecular Weight (Monoisotopic): 418.1740AlogP: -0.24#Rotatable Bonds: 5
Polar Surface Area: 128.56Molecular Species: ZWITTERIONHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.33CX Basic pKa: 8.95CX LogP: -3.24CX LogD: -3.25
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.52Np Likeness Score: 1.15

References

1. Botros S, Lipkowski AW, Larson DL, Stark PA, Takemori AE, Portoghese PS..  (1989)  Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine.,  32  (9): [PMID:2475628] [10.1021/jm00129a009]

Source